Tag: PFAS

RHP’s Frank Pagone to Join PFAS Panel at the 2026 National FETTI Conference

Jon Redmond /September 9, 2026

Conference Preview | September 23–25, 2026 | Chicago, Illinois RHP Risk Management’s Frank Pagone, PhD, CIH will join a multidisciplinary panel at the 2026 National FETTI Annual Conference, taking place…

Read-Across Is No Longer Optional: Why It Is Becoming Central to Modern Chemical Safety Assessment

Jon Redmond /September 8, 2026

Toxicology | Regulatory Insight Read-across has evolved from a data-gap-filling exercise into the framework that integrates NAMs, exposure science, and toxicokinetics to support modern risk assessment decisions. For years, read-across,…

What EPA’s New Biosolids Guidance Means for PFOA and PFOS Risk

Jon Redmond /September 3, 2026

PFAS | Regulatory Insight In July 2026, the U.S. Environmental Protection Agency (EPA) released proposed guidance for reducing potential risks from PFOA and PFOS in biosolids. If finalized, the guidance…

Microscopic image of titanium dioxide particles in white pigmented cosmetic products

OEHHA Establishes NSRLs for Respirable TiO₂ – What Does It Mean for Consumer Product Makers?

Jon Redmond /October 1, 2025

Key Takeaways: Effective October 1, 2025, California’s OEHHA establishes No Significant Risk Levels (NSRLs) for airborne, unbound, respirable titanium dioxide (TiO₂) particles, impacting manufacturers and users of TiO₂-containing products. RHP…

RHP’s Ashish Jachak, PhD, MBA Presents at 2025 Society of Toxicology Conference

Jon Redmond /March 26, 2025

RHP Risk Management’s Ashish Jachak, PhD, MBA, presented at the 2025 Society of Toxicology (SOT) conference in Orlando, FL. The SOT conference is attended by leading toxicologists, researchers, and industry…